Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hepatitis B virus (HBV) preS antigen refers to the preS domains (preS1 and preS2) found within the large envelope protein of HBV, known as hepatitis B surface antigen (HBsAg). The preS region plays a critical role in mediating HBV attachment to hepatocytes via interaction with sodium taurocholate co-transporting polypeptide (NTCP). It also contains multiple immunogenic T-cell and B-cell epitopes, making it a target for vaccine development. Furthermore, the C-terminal portion of pre-S interacts with capsid/core proteins during virion assembly.
Target of neutralizing antibodies; Inhibition of host cell entry via NTCP
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus preS Antigen (None).